Oppenheimer NVIDIA · NVDA

Oppenheimer Reiterates Outperform Rating and $265 Price Target on NVIDIA

1 min read Reproduced verbatim
Rating
Outperform
Unchanged
Target
$265
Upside
+42%
NVDA at $187 today
Oppenheimer and NVIDIA logos

What the analyst said

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

NVDA trades at $187. The 27 analysts who set a target in the last 3 months range from $270 to $515, with a median of $315. This $265 target is 16% below the median, the lowest on the Street.

Since the note NVDA has moved −15% (from $219). 12-month window: day 179 of 365, closes on May 12, 2027.

Track record

This callOpen: NVDA has not reached $265 yet. This 12-month target is scored on May 12, 2027.

Firm track recordOppenheimer: 64% of its 14 targets at least a year old were reached within 12 months; on NVIDIA, 3 of 3. Accuracy ranking →

Oppenheimer on NVIDIA

Oppenheimer price targets on NVIDIA

5 calls from August 28, 2025 to August 27, 2026. The target went from $225 to $315 (+40%). The rating stayed Buy.

Oppenheimer targetNVDA share price
  1. August 27, 2026Target raised from $265 (+19%)Buy$315
  2. August 20, 2026Kept the $265 targetBuy$265
  3. May 12, 2026 This noteKept the $265 targetBuy$265
  4. November 13, 2025Target raised from $225 (+18%)Buy$265
  5. August 28, 2025Earliest call shownBuy$225
Share

Other analysts on NVIDIA

Goldman SachsBuy Kept rating and price target Oct 21 $300maintained UBSBuy Kept rating and price target Oct 9 $300maintained Yorkville IvesBuy Initiated coverage Oct 7 $300 CantorBuy Kept rating and price target Oct 5 $350maintained CantorBuy Kept rating and price target Oct 1 $350maintained
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.